Traws Pharma (TRAW) Receivables - Other (2014 - 2019)

Traws Pharma (TRAW) posted quarterly Receivables - Other of $200000.0 for Q2 2019, up 471.43% quarter-over-quarter from $35000.0 in Q4 2018.

Traws Pharma (TRAW) Receivables - Other (2014 - 2019) Analysis & Trends

Traws Pharma (TRAW) has reported Receivables - Other for 5 consecutive years, with $200000.0 the latest figure, recorded in Q2 2019.

In Q2 2019, Receivables - Other changed N/A year-over-year to $200000.0; the TTM figure through Jun 2019 stood at $200000.0 (changed N/A YoY), while the FY2018 annual figure was $35000.0, changed N/A from the prior year.
Receivables - Other rose to $200000.0 in Q2 2019 per TRAW's latest filing, from $35000.0 in the prior quarter.
Across five years, Receivables - Other topped out at $1.5 million in Q3 2015 and bottomed at $31000.0 in Q4 2016.
Historically, Receivables - Other has averaged $662125.0 across 4 years, with a median of $534000.0 in 2016.
Annual changes were most pronounced in 2015 — Receivables - Other jumped 948.48% — and 2016, when it sank 97.76%.
Traws Pharma's Receivables - Other stood at $1.4 million in 2015, then tumbled by 97.76% to $31000.0 in 2016, then grew by 12.9% to $35000.0 in 2018, then jumped by 471.43% to $200000.0 in 2019.
Business Quant data shows TRAW's Receivables - Other at $200000.0 in Q2 2019, $35000.0 in Q4 2018, and $31000.0 in Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Traws Pharma	5.60 Mn	588,417.40	-

Download Data